Nevro to Report Fourth Quarter and Full-Year 2022 Financial Results

Nevro Corp. (NYSE: NVRO) will announce its financial results for Q4 and full-year 2022 on February 16, 2023, after market close.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Nevro Corp. (NYSE: NVRO) will announce its financial results for Q4 and full-year 2022 on February 16, 2023, after market close. The conference call will take place at 1:30 pm PT / 4:30 pm ET to discuss these results. The company aims to improve chronic pain treatment through its innovative 10 kHz Therapy, which has positively impacted over 100,000 patients globally. Investors can access the call via phone or through a live webcast available on Nevro's website. Regular updates regarding investor relations can also be found online.

Positive

Proprietary 10 kHz Therapy positively impacting over 100,000 patients.
Scheduled earnings report could indicate strong performance in chronic pain solutions.

Negative

None.

Argus Session date unavailable

-0.24% session move Open Argus

Details

News Market Reaction – NVRO

The recorded move for NVRO in the trading session of this news was -0.24%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

01/19/2023 - 07:00 AM EST

Company to Host Conference Call on Thursday, February 16, 2023 at 1:30 pm PT / 4:30 pm ET

REDWOOD CITY, Calif., Jan. 19, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that the company will report its financial results for the fourth quarter and full year ended December 31, 2022 after the market closes on February 16, 2023.

Management will host a conference call on February 16, 2023 to discuss fourth quarter and full-year 2022 financial results. The call will begin at 1:30 pm PT/ 4:30 pm ET. Investors interested in listening to the call may do so by dialing (888) 330-2443 in the U.S. or +1 (240) 789-2728 internationally, using Conference ID: 3583097. A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro's website at www.nevro.com.

Internet Posting of Information

Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at www.nevro.com. The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

About Nevro Corp.

Headquartered in Redwood City, California, Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. The company started with a simple mission to help more patients suffering from debilitating pain and developed its proprietary 10 kHz Therapy™, an evidence-based, non-pharmacologic innovation that has impacted the lives of more than 100,000 patients globally. Nevro's comprehensive HFX™ spinal cord stimulation (SCS) platform includes a Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy.

Senza^®, Senza II^®, Senza Omnia™, and HFX iQ™ are the only SCS systems that deliver Nevro's proprietary 10 kHz Therapy™. Nevro's unique support services provide every patient with an HFX Coach™ throughout their pain relief journey and every physician with HFX Cloud™ insights for enhanced patient and practice management.

SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo, HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo, RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are trademarks or registered trademarks of Nevro Corp. Patents covering Senza HFX iQ and other Nevro products are listed at Nevro.com/patents.

To learn more about Nevro, connect with us on LinkedIn, Twitter, Facebook and Instagram.

Investors and Media:
Julie Dewey, IRC
Nevro Corp.
Chief Corp Communications and Investor Relations Officer
650-433-3247 | julie.dewey@nevro.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nevro-to-report-fourth-quarter-and-full-year-2022-financial-results-301723061.html

SOURCE Nevro Corp.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What date will Nevro announce its Q4 2022 financial results?

Nevro will announce its Q4 2022 financial results on February 16, 2023.

What time is Nevro's conference call for financial results?

The conference call will be held at 1:30 pm PT / 4:30 pm ET on February 16, 2023.

How can I listen to Nevro's financial results call?

Investors can listen to the call by dialing (888) 330-2443 in the U.S. or +1 (240) 789-2728 internationally, using Conference ID: 3583097.

Where can I find more information about Nevro's investor relations?

More information can be found in the Investor Relations section of Nevro's website.

Nevro to Report Fourth Quarter and Full-Year 2022 Financial Results